Chester County News and Community Website
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA) announced that the U.S. Food and Drug Administration (FDA) this week issued a Complete Response Letter (CRL) regarding its New …
Verrica Receives Complete Response Letter from the FDA Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) this week announced its intent to file a New Drug Application (NDA) for avasopasem manganese (avasopasem) for the treatment of radiotherapy-induced severe …
Galera Announces Plan to Submit Avasopasem NDA by Year End Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) this week announced that it has received a written pre-investigational new drug (pre-IND) response from the U.S. Food and Drug Administration (FDA) …
Virpax Pharmaceuticals Receives FDA Response and Guidance on MMS019 Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced on Friday that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application …
FDA Extends New Drug Application Review Period for Verrica’s VP-102 Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that its resubmitted New Drug Application (NDA) for …
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application Read More